Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis Clinical Trial
Phase II prospective single-institutional study.
The aim of this Phase II prospective single-institutional study is to assess feasibility and early complications rate of Telelap ALF-X surgical treatment in obese patients affected by gynecological disease. ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment